CHE Chemed Corp
Price (delayed)
$598.5
Market cap
$8.76B
P/E Ratio
29.78
Dividend/share
$1.9
EPS
$20.1
Enterprise value
$8.62B
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of
Highlights
The EPS has increased by 11% YoY
The net income has grown by 11% year-on-year
The debt has dropped by 71% since the previous quarter but it is up by 10% year-on-year
Chemed's quick ratio has decreased by 26% from the previous quarter and by 15% YoY
Chemed's equity has decreased by 9% from the previous quarter
Key stats
What are the main financial stats of CHE
Market
Valuations
Earnings
Shares outstanding
14.64M
Market cap
$8.76B
Enterprise value
$8.62B
Price to earnings (P/E)
29.78
Price to book (P/B)
8.01
Price to sales (P/S)
3.7
EV/EBIT
21.49
EV/EBITDA
18.57
EV/Sales
3.55
Revenue
$2.43B
Gross profit
$854.35M
Operating income
$366.49M
Net income
$302M
EBIT
$401.25M
EBITDA
$464.29M
Free cash flow
$371.28M
Per share
Balance sheet
Liquidity
EPS
$20.1
EPS diluted
$19.89
Free cash flow per share
$24.71
Book value per share
$74.69
Revenue per share
$161.83
TBVPS
$60.54
Total assets
$1.67B
Total liabilities
$549.58M
Debt
$42.31M
Equity
$1.12B
Working capital
$109.05M
Debt to equity
0.04
Current ratio
1.38
Quick ratio
1.22
Net debt/EBITDA
-0.29
Margins
Efficiency
Dividend
EBITDA margin
19.1%
Gross margin
35.1%
Net margin
12.4%
Operating margin
15.1%
Return on assets
17.5%
Return on equity
25.5%
Return on invested capital
67.5%
Return on capital employed
29%
Return on sales
16.5%
Dividend yield
0.32%
DPS
$1.9
Payout ratio
9.5%
CHE stock price
How has the Chemed stock price performed over time
Intraday
0.29%
1 week
1.85%
1 month
8.06%
1 year
-7.61%
YTD
12.97%
QTD
12.97%
Financial performance
How have Chemed's revenue and profit performed over time
Revenue
$2.43B
Gross profit
$854.35M
Operating income
$366.49M
Net income
$302M
Gross margin
35.1%
Net margin
12.4%
The net income has grown by 11% year-on-year
Chemed's operating income has increased by 8% YoY
The revenue rose by 7% year-on-year and by 2.3% since the previous quarter
CHE's gross profit is up by 7% year-on-year
Growth
What is Chemed's growth rate over time
Valuation
What is Chemed stock price valuation
P/E
29.78
P/B
8.01
P/S
3.7
EV/EBIT
21.49
EV/EBITDA
18.57
EV/Sales
3.55
The EPS has increased by 11% YoY
The price to earnings (P/E) is 3.4% higher than the 5-year quarterly average of 28.8
The P/B is 11% less than the 5-year quarterly average of 9.0 but 8% more than the last 4 quarters average of 7.4
Chemed's equity has decreased by 9% from the previous quarter
The revenue rose by 7% year-on-year and by 2.3% since the previous quarter
CHE's P/S is 2.8% above its 5-year quarterly average of 3.6
Efficiency
How efficient is Chemed business performance
The ROE has contracted by 7% YoY
The ROS has increased by 6% YoY
Dividends
What is CHE's dividend history
DPS
$1.9
Dividend yield
0.32%
Payout ratio
9.5%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Chemed financials performed over time
Chemed's quick ratio has decreased by 26% from the previous quarter and by 15% YoY
CHE's current ratio is down by 25% from the previous quarter and by 14% YoY
The debt is 96% smaller than the equity
The debt has dropped by 71% since the previous quarter but it is up by 10% year-on-year
CHE's debt to equity has dropped by 67% since the previous quarter but it is up by 33% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.